Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from imexon and docetaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

Question 4

What criteria will determine if I can participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this trial affect my daily life and activities?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients clinical trial (NCT00327288). Contact the study team or your healthcare provider for specific answers.

What this study is about